Emerging pharmacotherapies for diabetic macular edema

Author： Furlani Bruno A   Meyer Carsten H   Rodrigues Eduardo B   Maia Mauricio   Farah Michel E   Penha Fernando M   Holz Frank G  

Publisher： Informa Healthcare

ISSN： 1472-8214

Source： Expert Opinion on Emerging Drugs, Vol.12, Iss.4, 2007-11, pp. : 591-603

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pegaptanib octasodium for the treatment of diabetic macular edema

By Schartman Jerome P   Coney Joseph M   Hornik Joan H   Miller David G  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 8, 2011-06 ,pp. : 1317-1323

Informa Healthcare

Access to resources Recommend Favorite

Anti-VEGF Molecules for the Management of Diabetic Macular Edema

By  

Current Pharmaceutical Design, Vol. 21, Iss. 32, 2015-10 ,pp. : 4731-4737

Bentham Science Publishers

Access to resources Recommend Favorite

Subthreshold Laser Therapy for Diabetic Macular Edema: Metabolic and Safety Issues

By  

Current Medicinal Chemistry, Vol. 20, Iss. 26, 2013-09 ,pp. : 3267-3271

Bentham Science Publishers

Access to resources Recommend Favorite

Diabetic Macular Edema: Correlations with Available Diabetes Therapies - Evidence Across a Qualitative Review of Published Literature from MEDLINE and EMBASE

By Merante Domenico  

Drug Safety, Vol. 33, Iss. 8, 2010-08 ,pp. : 643-652

Adis International

Access to resources Recommend Favorite

Treatment of diabetic macular edema with sustained-release glucocorticoids: intravitreal triamcinolone acetonide, dexamethasone implant, and fluocinolone acetonide implant

By Ciulla Thomas A   Harris Alon   McIntyre Nathaniel   Jonescu-Cuypers Christian  

Expert Opinion on Pharmacotherapy, Vol. 15, Iss. 7, 2014-05 ,pp. : 953-959

Informa Healthcare

Access to resources Recommend Favorite